On June 12, 2019, InSymbiosis was acquired by Camargo. The solutions now available through Camargo Research Group are the same as those previously offered through InSymbiosis.
In addition to the nonclinical development support you have come to know through InSymbiosis, together as Camargo, we deliver more. Our portfolio accelerates your path to market through integrated solutions including Development and Regulatory Strategy, CMC, and Clinical & PK. Explore our comprehensive solutions over on the Camargo website.
For more information about the acquisition, read our press release.